Polarean Imaging CEO Richard Hullihen, Vadim Alexander on BiVictriX Therapeutics, Dan Lane & Alan Green

May 27, 01:53 PM
On the Vox Markets Podcast Today: 27th May 2021

Richard Hullihen, CEO of Polarean Imaging #POLX discusses the article on hyperpolarised xenon by the Oxford Biomedical Research Centre concerning a study carried out in longer-term lung damage after COVID-19.

Vadim Alexandre, Head of Healthcare at SP Angel discusses the proposed reverse takeover of Motif Bio #MTFB by BiVictriX Therapeutics Limited #BVX, a biotech company applying a novel approach to develop safer, more effective cancer therapies.

(Interview starts at 15 minutes and 40 seconds)

Dan Lane, Senior Analyst at Freetrade discusses: Synairgen #SNG OnTheMarket #OTMP Cora Gold #CORA Tremor International #TRMR & Warehouse REIT #WHR

(Interview starts at 30 minutes and 58 seconds)

Alan Green CEO of Brand Communications talks about: Team17 #TM17 & Bidstack #BIDS

(Interview starts at 47 minutes and 14 seconds)

Vox Markets is revolutionising the way companies engage with shareholders and the stock market at large. By aggregating IR and digital content onto one secure and compliant platform, Vox Markets has established itself as the go-to resource for the investment community.

#VoxMarkets #StockMarket #LivePrices #StockMarketNews #Money #Investing #Investments #Finance #Business #Podcast